Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Protein Engineering. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121022786A reveals a novel AmDH enzyme for high-purity chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112391372B reveals a novel glutamate decarboxylase mutant enabling high-yield food-grade GABA fermentation with expanded pH activity and industrial scalability.
Patent CN114277020B reveals a novel nitrilase mutant for phenylacetic acid synthesis. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN119040289B enables high-purity chiral amine production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN110904086A reveals a novel tryptophanase mutant for D-tryptophan production. Discover cost-effective biocatalytic solutions and reliable supply chain strategies.
Patent CN114667346A reveals novel EanB mutants for ergothioneine production. Discover cost-effective enzymatic routes replacing slow fungal fermentation for reliable supply.
Patent CN113174377B reveals a stable carbonyl reductase mutant for synthesizing (2R,3S)-MPGM with 100% theoretical yield, offering significant cost reduction in API manufacturing.
Patent CN105543201B details a mutant enzyme boosting 7-ACA yield. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Patent CN113308443B reveals a mutant monooxygenase boosting azaphilone yield to 92.8%. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN116064449A discloses stable transaminase mutants for bulky chiral amines. Enables green synthesis, cost reduction, and reliable supply for pharmaceutical intermediates.
Patent CN110628739B reveals high-efficiency enzymatic synthesis for chiral amines. Achieve >99% ee and reduced costs with scalable biocatalytic solutions.
Novel mutant enzyme method for PLP production ensures high purity and supply stability for global pharmaceutical and nutrition manufacturers seeking reliable partners.
Patent CN118726300A reveals a novel transaminase mutant for producing agrochemical intermediates with high optical purity and reduced manufacturing costs.
Patent CN113293152B details short-chain dehydrogenase mutants for asymmetric reduction. This report analyzes cost reduction in chiral alcohol manufacturing and supply chain reliability for global buyers.
Patent CN114164198B enables enzymatic synthesis of chiral intermediates. This route offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN112852768B reveals engineered carbonyl reductase mutants for high-purity chiral nitrile synthesis, offering significant cost reduction in API manufacturing and scalable green chemistry solutions.
Patent CN106754806B discloses a high-efficiency transaminase for synthesizing (R)-3-aminobutanol, offering superior substrate tolerance and eliminating organic cosolvents for cost-effective manufacturing.
Patent CN114107236B reveals a high-efficiency ketoreductase mutant for synthesizing Ibrutinib intermediates, offering superior yield and scalability for pharmaceutical manufacturing.
Patent CN118028274A details a novel acylase mutant enhancing (S)-o-chlorophenylglycine synthesis. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.